To: incomep who wrote (6848 ) 4/11/1998 10:41:00 PM From: BigKNY3 Read Replies (3) | Respond to of 23519
Incomep <<. Did not you mention months ago on this thread that you never short stocks, and you are a pro-knowledge. Ha, I guess, muse helps you grow on many ways.>> I am not sure what you are trying to say. << My understanding is that the clinical trial demonstrated that dosage lower than 100 mg has very low success rate for the real ED patients, which was verified by Edderd.>> The usual dosage rate is 50 mg which has a 65%-80% efficacy rate. << Mr. Diceguy (post 1869) mentioned a sever headache lasts till noon after he took the 50 mg pill early in the morning (I think 5 AM), was this mentioned in the pfezer's clinical trial?>> Headaches are the #1 adverse reaction for Viagra (16% of all patients) << Do I smell a rat. I think so. Longtime ago, the big guys created a hype which resulted our poor small longs left holding the bag. This time, I hope it is not the turn for our poor small shorts (no pun intended).>> Still not sure who you think is the rat. <<I am afraid that I am going to long VVUS this coming Monday when everything is bleak. I might be wrong, but I know this is my blood-earning money.>> Before you invest in VVUS on Monday, I suggest thinking about the following: 1. Why wasn't the revised MUSE package insert discussed in the conference call? fda.gov 2. Why was the Q & A section of the VVUS conference call edited from the taped repeat conference call? 3. The ED market is rapidly changing. The price of VVUS will not stabilize until the market does. 4. Do you think that the VVUS management has the skills to successfully manage MUSE in the next year? I suggest reviewing the results of their Impotence Awareness campaign and listening to their plans revealed during the conference call, <<Integrity is a virtue.>> Definitely agree! Good investing! BigKNY3